Evidence map›Paper›PMID 31255170›Full record

ArticleJournal of neuroinflammation2019

Epigenetic suppression of liver X receptor β in anterior cingulate cortex by HDAC5 drives CFA-induced chronic inflammatory pain.

Yu-Jiao Li, Kun Zhang, Ting Sun, Jian Wang, Yan-Yan Guo, Le Yang, Qi Yang, Yan-Jiao Li, Shui-Bing Liu, Ming-Gao Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yu-Jiao LiDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Kun ZhangDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Ting SunDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Jian WangDepartment of Ambulatorium, 94750 Army Hospital, Liancheng, 366200, FuJian Province, People's Republic of China.
Yan-Yan GuoDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Le YangDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Qi YangDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China.
Yan-Jiao LiDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, People's Republic of China.
Shui-Bing LiuDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, People's Republic of China.
Ming-Gao ZhaoDepartment of Pharmacy, Precision Pharmacy & Drug Development Center, The Second Affiliated Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, People's Republic of China. minggao@fmmu.edu.cn.
Yu-Mei WuDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, People's Republic of China. yumeiwu@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-1956-3845
Air Force Medical University · CNShaanxi Provincial Hospital of Traditional Chinese Medicine · CN

Funding

Major International Cooperation in Shaanxi 2017KW-ZD-01National Natural Science Foundation of China 81571328National Natural Science Foundation of China 81771469
6 · The paper itself

Abstract

backgroundLiver X receptors (LXRs), including LXRα and LXRβ, are key regulators of transcriptional programs for both cholesterol homeostasis and inflammation in the brain. Here, the modes of action of LXRs and the epigenetic mechanisms regulating LXRβ expression in anterior cingulate cortex (ACC) of chronic inflammatory pain (CIP) are investigated.

methodsThe deficit of LXR isoform and analgesic effect of LXR activation by GW3965 were evaluated using the mouse model of CIP induced by hindpaw injection of complete Freund's adjuvant (CFA). The mechanisms involved in GW-mediated analgesic effects were analyzed with immunohistochemical methods, ELISA, co-immunoprecipitation (Co-IP), Western blot, and electrophysiological recording. The epigenetic regulation of LXRβ expression was investigated by chromatin immunoprecipitation, quantitative real-time PCR, and sequencing.

resultsWe revealed that CFA insult led to LXRβ reduction in ACC, which was associated with upregulated expression of histone deacetylase 5 (HDAC5), and knockdown of LXRβ by shRNA led to thermal hyperalgesia. Co-IP showed that LXRβ interacted with NF-κB p65 physically. LXRβ activation by GW3965 exerted analgesic effects by inhibiting the nuclear translocation of NF-κB, reducing the phosphorylation of mitogen-activated protein kinases (MAPKs) in ACC, and decreasing the promoted input-output and enhanced mEPSC frequency in ACC neurons after CFA exposure. In vitro experiments confirmed that HDAC5 triggered histone deacetylation on the promoter region of Lxrβ, resulting in downregulation of Lxrβ transcription.

conclusionThese findings highlight an epigenetic mechanism underlying LXRβ deficits linked to CIP, and LXRβ activation may represent a potential novel target for the treatment of CIP with an alteration in inflammation responses and synaptic transmission in ACC.

Indexed as

AnimalsBase SequenceChronic PainEpigenesis, GeneticFreund's AdjuvantGyrus CinguliHistone DeacetylasesInflammationLiver X ReceptorsMaleMiceMice, Inbred C57BLFreund's AdjuvantHdac5 protein, mouseHistone DeacetylasesLiver X ReceptorsAnterior cingulate cortexChronic inflammatory painHistone modificationLiver X receptorsNeuroinflammationNeurotransmission

Identifiers

PMID31255170
PMCPMC6599528
OpenAlexW2953944045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.